Novel selective HDAC1/2 inhibitor 2-aminobenzamide derivative potently induces fetal hemoglobin (2024)
- Authors:
- USP affiliated authors: FERREIRA, LEONARDO LUIZ GOMES - IFSC ; ANDRICOPULO, ADRIANO DEFINI - IFSC ; CHELUCCI, RAFAEL CONSOLIN - IFSC
- Unidade: IFSC
- DOI: 10.1182/blood-2024-208290
- Subjects: METABOLISMO CELULAR; HEMOGLOBINAS; CRISTALOGRAFIA
- Language: Inglês
- Imprenta:
- Publisher place: Washington, DC
- Date published: 2024
- Source:
- Conference titles: American Society of Hematology Annual Meeting
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
PASTRE, Victor Gabriel de Faria et al. Novel selective HDAC1/2 inhibitor 2-aminobenzamide derivative potently induces fetal hemoglobin. Blood. Washington, DC: Instituto de Física de São Carlos, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2024-208290. Acesso em: 04 ago. 2025. , 2024 -
APA
Pastre, V. G. de F., Pavan, A. R., Lanaro, C., Albuquerque, D. M. de, Chelucci, R. C., Ferreira, L. L. G., et al. (2024). Novel selective HDAC1/2 inhibitor 2-aminobenzamide derivative potently induces fetal hemoglobin. Blood. Washington, DC: Instituto de Física de São Carlos, Universidade de São Paulo. doi:10.1182/blood-2024-208290 -
NLM
Pastre VG de F, Pavan AR, Lanaro C, Albuquerque DM de, Chelucci RC, Ferreira LLG, Andricopulo AD, Santos JL dos, Costa FF. Novel selective HDAC1/2 inhibitor 2-aminobenzamide derivative potently induces fetal hemoglobin [Internet]. Blood. 2024 ; No 2024 3868-3869.[citado 2025 ago. 04 ] Available from: https://doi.org/10.1182/blood-2024-208290 -
Vancouver
Pastre VG de F, Pavan AR, Lanaro C, Albuquerque DM de, Chelucci RC, Ferreira LLG, Andricopulo AD, Santos JL dos, Costa FF. Novel selective HDAC1/2 inhibitor 2-aminobenzamide derivative potently induces fetal hemoglobin [Internet]. Blood. 2024 ; No 2024 3868-3869.[citado 2025 ago. 04 ] Available from: https://doi.org/10.1182/blood-2024-208290 - Design, synthesis and in vitro evaluation of a series of arylmorpholine derivative compounds against chagas disease
- Potente reativação da produção de hemoglobina fetal por novo inibidor seletivo de histona deacetilase 1 e 2
- Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease
- Evaluation and discovery of novel benzothiazole derivatives as promising hits against Leishmania infantum
- Hit-to-lead optimization of a benzene sulfonamide series for potential antileishmanial agents
- Discovery of arylpiperazines with broad-spectrum antimicrobial activity and favorable pharmacokinetic profiles
- Novel brominated vinylic fatty acids effectively inhibit the leishmania topoisomerase IB enzyme mediated by halogen bond formation
- 3D QSAR studies for a series of Trypanosoma cruzi dehydrogenase inhibitors
- Saúde e bem-estar
- World chagas disease day and the new road map for neglected tropical diseases. [Editorial]
Informações sobre o DOI: 10.1182/blood-2024-208290 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
3234727.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
